Terns Pharmaceuticals, Inc. financial data

Symbol
TERN on Nasdaq
Location
Foster City, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 10 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 2403% % -7.4%
Debt-to-equity 5.1% % 11%
Return On Equity -30% % 8.6%
Return On Assets -28% % 9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 90,079,781 shares 6.1%
Common Stock, Shares, Outstanding 87,511,470 shares 3.1%
Entity Public Float $426,783,524 USD 4.3%
Common Stock, Value, Issued $9,000 USD 12%
Weighted Average Number of Shares Outstanding, Basic 91,701,529 shares 18%
Weighted Average Number of Shares Outstanding, Diluted 91,701,529 shares 18%

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense $31,481,000 USD 3.5%
Costs and Expenses $108,475,000 USD 8.5%
Operating Income (Loss) $108,475,000 USD -8.5%
Nonoperating Income (Expense) $14,278,000 USD 17%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $94,197,000 USD -7.3%
Income Tax Expense (Benefit) $238,000 USD -12%
Net Income (Loss) Attributable to Parent $94,435,000 USD -7.2%
Earnings Per Share, Basic -1 USD/shares 14%
Earnings Per Share, Diluted -1 USD/shares 14%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $150,698,000 USD -44%
Marketable Securities, Current $144,937,000 USD 41%
Assets, Current $300,295,000 USD -20%
Property, Plant and Equipment, Net $59,000 USD -80%
Operating Lease, Right-of-Use Asset $938,000 USD -32%
Other Assets, Noncurrent $359,000 USD 541%
Assets $301,651,000 USD -20%
Accounts Payable, Current $2,946,000 USD 65%
Employee-related Liabilities, Current $4,241,000 USD -0.91%
Liabilities, Current $15,387,000 USD 35%
Accrued Income Taxes, Noncurrent $1,628,000 USD 24%
Operating Lease, Liability, Noncurrent $570,000 USD -45%
Liabilities $17,585,000 USD 28%
Accumulated Other Comprehensive Income (Loss), Net of Tax $109,000 USD -32%
Retained Earnings (Accumulated Deficit) $494,117,000 USD -24%
Stockholders' Equity Attributable to Parent $284,066,000 USD -22%
Liabilities and Equity $301,651,000 USD -20%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $24,440,000 USD -7.2%
Net Cash Provided by (Used in) Financing Activities $0 USD -100%
Net Cash Provided by (Used in) Investing Activities $1,959,000 USD -76%
Common Stock, Shares Authorized 150,000,000 shares 0%
Common Stock, Shares, Issued 87,511,470 shares 3.1%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $22,416,000 USD -51%
Deferred Tax Assets, Valuation Allowance $78,220,000 USD 31%
Deferred Tax Assets, Gross $620,000 USD 241%
Operating Lease, Liability $1,029,000 USD -21%
Payments to Acquire Property, Plant, and Equipment $0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $94,486,000 USD -8.5%
Lessee, Operating Lease, Liability, to be Paid $1,145,000 USD -26%
Property, Plant and Equipment, Gross $2,114,000 USD -0.05%
Operating Lease, Liability, Current $459,000 USD 69%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $116,000 USD -52%
Deferred Tax Assets, Operating Loss Carryforwards $28,004,000 USD 41%
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $5,542,000 USD -26%
Additional Paid in Capital $778,065,000 USD 1.8%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $55,000 USD -33%
Share-based Payment Arrangement, Expense $13,067,000 USD -18%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%